Radioprotective Effects of Amifostine, L-Carnitine and Vitamin E in Preventing Early Salivary Gland Injury due to Radioactive Iodine Treatment
dc.authorid | Torun, Nese/0000-0002-5597-676X | |
dc.authorwosid | Torun, Nese/AAE-2718-2021 | |
dc.contributor.author | Torun, Nese | |
dc.contributor.author | Muratli, Asli | |
dc.contributor.author | Serim, Burcu Dirlik | |
dc.contributor.author | Ergulen, Alev | |
dc.contributor.author | Altun, Gulay Durmus | |
dc.date.accessioned | 2024-06-12T11:13:21Z | |
dc.date.available | 2024-06-12T11:13:21Z | |
dc.date.issued | 2019 | |
dc.department | Trakya Üniversitesi | en_US |
dc.description.abstract | Objective: Standard treatment of differentiated thyroid cancer includes total thyroidectomy and high-dose Radioactive Iodine Therapy (RIT) for ablation of remnant thyroid tissue. When administered systemically, RIT can cause radiation-induced damage in non-targeted normal tissues. The aim of the present study was to compare the protective effects of amifostine (AMI), L-Carnitine (LC), and Vitamin E (EVIT) against high dose radioactive iodine treatment induced Salivary Gland (SG) damage using SG scintigraphy and histopathological examination. Methods: Forty adult guinea pigs were studied. Twenty guinea pigs receive 555-660 MBq (131)Iodine intraperitoneally (IP) to ablate the thyroid and impair the parenchymal function of the SGs. The animals were divided into eight groups as follows: (1) Group 1 (control): 1 mL IP PS (physiological saline); (2) Group 2: single dose of 200 mg/kg IP AMI one hour prior to 1 mL IP PS; (3) Group 3: 200 mg/kg IP LC and 1 mL IP PS for 10 days; (4) Group 4: 40 mg/kg intramuscular (IM) EVIT and 1 mL IP PS for 10 days; (5) Group 5: IP RIT after premedication; (6) Group 6: Single dose of 200 mg/kg IP AMI one hour prior to RIT and IP RIT after premedication; (7) Group 7: IP RIT after premedication and 200 mg/kg IP LC for 10 days starting one day before RIT; and (8) Group 8: IP RIT after premedication and 40 mg/kg IM EVIT for 10 days starting one day before RIT. Scintigraphy was performed 1 month after treatment. SGs were examined by light microscopy and a histopathological scoring system was used to assess the degree of SG damage. Results: There were significant differences in the body weight and thyroid hormone levels between the groups after treatment. Conclusion: The individual use of AMI, LC and EVIT for radioprotection yield different levels of protection against radioactive iodine treatment injury in SGs; however, none of the agents could provide absolute protection at the doses administered in this experimental model. | en_US |
dc.identifier.doi | 10.2174/1573405614666180314150808 | |
dc.identifier.endpage | 404 | en_US |
dc.identifier.issn | 1573-4056 | |
dc.identifier.issn | 1875-6603 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 31989909 | en_US |
dc.identifier.scopus | 2-s2.0-85065960811 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 395 | en_US |
dc.identifier.uri | https://doi.org/10.2174/1573405614666180314150808 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14551/23511 | |
dc.identifier.volume | 15 | en_US |
dc.identifier.wos | WOS:000464162000007 | en_US |
dc.identifier.wosquality | N/A | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Bentham Science Publ Ltd | en_US |
dc.relation.ispartof | Current Medical Imaging Reviews | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Radioactive Iodine Therapy | en_US |
dc.subject | Salivary Gland | en_US |
dc.subject | Amifostine | en_US |
dc.subject | L-Carnitine | en_US |
dc.subject | Vitamin E | en_US |
dc.subject | Thyroid Cancer | en_US |
dc.subject | Radioiodine Therapy | en_US |
dc.subject | Radiation | en_US |
dc.subject | Scintigraphy | en_US |
dc.subject | Combination | en_US |
dc.subject | Dysfunction | en_US |
dc.subject | Protection | en_US |
dc.subject | Toxicity | en_US |
dc.title | Radioprotective Effects of Amifostine, L-Carnitine and Vitamin E in Preventing Early Salivary Gland Injury due to Radioactive Iodine Treatment | en_US |
dc.type | Review Article | en_US |